Gilead Sciences (GILD) Change in Receivables (2009 - 2026)
Gilead Sciences (GILD) recorded Change in Receivables of $333 million in Q2 2026, up 14.0% from $292 million a year earlier.
Powered by 
Analysis
Gilead Sciences (GILD) Change in Receivables (2009 - 2026) Analysis & Trends
On a TTM basis, Gilead Sciences' Change in Receivables came in at $353 million as of Jun 30, 2026; for FY2025, it came in at $367 million.
- Annual Change in Receivables has a five-year compound annual growth rate of -20.7% (FY2020 to FY2025).
- Across earlier years, Change in Receivables came in at -$139 million in FY2024, -$157 million in FY2023, $406 million in FY2022 and -$313 million in FY2021.
- Quarterly Change in Receivables has ranged from -$699 million in Q1 2022 to $612 million in Q3 2023 over the past five years.
- Peak year-over-year performance for Change in Receivables in the last five years was growth of 906.9% in Q2 2025, against a decline of 81.0% in Q2 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at -$134 million (Q1 2026), -$179 million (Q4 2025) and $333 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | -188.00 Mn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | 1.37 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | - |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 1.09 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | 333.00 Mn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | - |
| 10 | Vertex Pharmaceuticals | 135.58 Bn | 107.59 Bn | 2.84 Bn | 140.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 333.00 Mn |
| Mar 31, 2026 | -134.00 Mn |
| Dec 31, 2025 | -179.00 Mn |
| Sep 30, 2025 | 333.00 Mn |
| Jun 30, 2025 | 292.00 Mn |
| Mar 31, 2025 | -79.00 Mn |
| Dec 31, 2024 | -72.00 Mn |
| Sep 30, 2024 | -162.00 Mn |
| Jun 30, 2024 | 29.00 Mn |
| Mar 31, 2024 | 66.00 Mn |
| Dec 31, 2023 | -220.00 Mn |
| Sep 30, 2023 | 612.00 Mn |
| Jun 30, 2023 | 86.00 Mn |
| Mar 31, 2023 | -635.00 Mn |
| Dec 31, 2022 | 281.00 Mn |
| Sep 30, 2022 | 372.00 Mn |
| Jun 30, 2022 | 452.00 Mn |
| Mar 31, 2022 | -699.00 Mn |
| Dec 31, 2021 | -41.00 Mn |
| Sep 30, 2021 | 422.00 Mn |
API Access
Gilead Sciences Change in Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-receivables&ticker=GILD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-receivables", "ticker": "GILD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=change-in-receivables&ticker=GILD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();